Silo Pharma, Inc. (SILO) Q4 2025 Annual Earnings

Screener

Reported March 27, 2026 · After market close

Revenue$18.0K

EPS-$0.07

Next report

Dec 2, 2026 (in 2 months)

Revenue estimate$18.0K

EPS estimate-$4.80

Versus estimates

Revenue

Q1 2026$18.0KBeat by $26.0

Q4 2025$18.0K

Q3 2025$18.0K Q2 2025$18.0K Q1 2025$18.0K

Diluted EPS

Q2 2026-$0.76Miss by $0.44 Q1 2026-$0.12Beat by $0.20

Q4 2025-$0.07

Q3 2025-$0.12 Q2 2025-$0.19 Q1 2025-$0.23

FAQ

When did Silo Pharma, Inc. report Q4 2025 earnings?: Silo Pharma, Inc. (SILO) reported Q4 2025 earnings on March 27, 2026 after market close.
What were Silo Pharma, Inc.'s Q4 2025 revenue and EPS?: Silo Pharma, Inc. reported revenue of $18.0K and eps of $-0.07 for Q4 2025.
How did Silo Pharma, Inc.'s Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 0.0% from $18.0K a year earlier and eps grew 83.9% from $-0.41.
Where can I find Silo Pharma, Inc.'s Q4 2025 SEC filings?: You can read the 10-K periodic report (0001213900-26-035576) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Silo Pharma, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk